A number of the genes our analysis highlights as potential drug targets have well established roles in MM, for example MAF, IKZF3, NFKB1 (part of the NF-κB complex) and PRDM1(Supplementary Table 1). This evidence concerns the gene PRDM1 and Miyoshi myopathy.